StockData
Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd

TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$41.31−0.19 (-0.46%)

Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –

Teva Pharmaceutical Industries EBITDA by Quarter

EBITDA (GAAP Operating Income + Depreciation & Amortization) ($M)

Teva Pharmaceutical Industries EBITDA: $959M in Q3 2026, down 15.2% from a year earlier.

Latest, Q3 2026
959
Period ended Sep 30, 2026
Change on a year earlier
-15.2%
1,131 in Q3 2025
History
20 quarters
Since Q4 2021
Sources
16
Documents cited below

Where the Q3 2026 figure comes from

“|| EBITDA | 959 | 1,131 | 1,861 | 2,599”

Source: Form 8-K Earnings Release (0001171843-26-007054) ↗

Reported in SEC Form 10-K / Form 10-Q / Form 8-K Earnings Releases.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEBITDA (GAAP Operating Income + Depreciation & Amortization) ($M)Year on yearSource
Q3 2026Sep 30, 2026959-15.2%Form 8-K Earnings Release (0001171843-26-007054) ↗
Q2 2026Jun 30, 202610-98.6%Form 8-K Earnings Release (0001171843-26-004974) ↗
Q1 2026Mar 31, 2026892+16.9%Form 8-K Earnings Release (0001171843-26-002796) ↗
Q4 2025Dec 31, 2025560+138.3%Form 8-K Earnings Release (0001171843-26-000462) ↗
Q3 2025Sep 30, 20251,131+443.8%Form 8-K Earnings Release (0001171843-25-007000) ↗
Q2 2025Jun 30, 2025705+177.6%Form 8-K Earnings Release (0001171843-25-004808) ↗
Q1 2025Mar 31, 2025763+1,313.0%Form 8-K Earnings Release (0001171843-25-002849) ↗
Q4 2024Dec 31, 2024235-77.0%Form 8-K Earnings Release (0001171843-25-000493) ↗
Q3 2024Sep 30, 2024208-67.4%Form 8-K Earnings Release (0001171843-24-006034) ↗
Q2 2024Jun 30, 2024254-173.4%Form 8-K Earnings Release (0001171843-24-004270) ↗
Q1 2024Mar 31, 202454-82.4%Form 8-K Earnings Release (0001193125-24-133759) ↗
Q4 2023Dec 31, 20231,0200.0%Form 8-K Earnings Release (0001171843-25-000493) ↗
Q3 2023Sep 30, 2023639-13.6%Form 8-K Earnings Release (0001157523-23-001677) ↗
Q2 2023Jun 30, 2023-346-41.4%Form 8-K Earnings Release (0001157523-23-001212) ↗
Q1 2023Mar 31, 2023306-178.5%Form 8-K Earnings Release (0001157523-23-000797) ↗
Q4 2022Dec 31, 20221,020-285.5%Form 8-K Earnings Release (0001157523-24-000137) ↗

Cite this data

StockData. (2026). Teva Pharmaceutical Industries EBITDA ($M), quarterly Q4 2021–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/ng-ebitda

See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?